Show me a contemporary phase 1 or phase 2 trial that has ever reported on 80% confidence intervals that is now approved for use in cancer.
Herceptin is a good example. Show me a single study where Herceptin was reported at an 80% CI.
Your questions are garbage and are intended to distract from the critical point I am making and reinforcing with CheckVacc preclinical data. The in vivo models are weak.
---
Mate, can you read? Injected = intratumoral
Mason: "The only way the researchers can get a significant difference TO PBS is by injecting the anti-pd1 intratumorally (2nd image)"
"For the injected tumors, the combination group significantly delayed tumor growth compared to the PBS control group..."
PBS is saline solution.
Challenge is out there for anyone on this forum to show me a robust preclinical study of Oncarlytics in vivo.
Why IMU is a multi multi bagger, page-25124
Add IMU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
5.7¢ |
Change
0.001(1.79%) |
Mkt cap ! $418.9M | |||
| Open | High | Low | Value | Volume |
| 5.6¢ | 5.7¢ | 5.4¢ | $461.9K | 8.347M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 7 | 1082545 | 5.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 5.7¢ | 603058 | 6 |
View Market Depth
| Last trade - 16.10pm 19/07/2024 (20 minute delay) ? |
| IMU (ASX) Chart |